1. Home
  2. RRC vs PTGX Comparison

RRC vs PTGX Comparison

Compare RRC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

N/A

Current Price

$49.03

Market Cap

9.8B

Sector

Energy

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$133.40

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RRC
PTGX
Founded
1976
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
9.3B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
RRC
PTGX
Price
$49.03
$133.40
Analyst Decision
Hold
Strong Buy
Analyst Count
20
14
Target Price
$52.26
★ $178.57
AVG Volume (30 Days)
★ 5.5M
635.4K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 0.80%
N/A
EPS Growth
★ 151.38
N/A
EPS
★ 3.02
2.35
Revenue
★ $3,115,515,000.00
N/A
Revenue This Year
$19.92
$1,093.12
Revenue Next Year
$4.34
N/A
P/E Ratio
★ $17.25
$61.01
Revenue Growth
★ 28.90
N/A
52 Week Low
$32.68
$77.00
52 Week High
$56.99
$160.81

Technical Indicators

Market Signals
Indicator
RRC
PTGX
Relative Strength Index (RSI) 55.40 40.99
Support Level $36.29 $127.45
Resistance Level $56.99 $143.61
Average True Range (ATR) 2.04 5.41
MACD -0.16 -0.29
Stochastic Oscillator 48.62 31.40

Price Performance

Historical Comparison
RRC
PTGX

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: